Dr. Yasser Albogami is an academic leader and innovator at the intersection of artificial intelligence, real-world evidence (RWE), and health technology assessment (HTA). As Vice Dean for Development and Associate Professor of Pharmaceutical Outcomes and Policy at the College of Pharmacy, King Saud University, where he leads initiatives that unite academic excellence with data-driven transformation.

Dr. Albogami earned his Ph.D. in Pharmaceutical Outcomes and Policy from the University of Florida and completed his Master of Public Health from the University of Southern California. His research explores how AI and data science can generate actionable insights for evaluating medical technologies, therapeutic outcomes, and innovation value.

A contributor to several national healthcare and regulatory initiatives, Dr. Albogami has contributed in advancing evidence-based policy and pharmaceutical safety. His work has informed the development of frameworks that strengthen pharmaceutical data governance, real-world data utilization, and health policy decision-making, establishing research excellence as a national priority.

Within Saudi Arabia's healthcare and digital innovation ecosystem, Dr. Albogami serves as an advisor on strategic projects, collaborating with public and private institutions to catalyze impactful initiatives that enhance RWE infrastructure and health innovation strategy.

Dr. Albogami works closely with founders and startups to transform promising ideas into evidence ready, regulation aware, and market-accessible solutions. His mentorship uniquely combines scientific rigor with business acumen, guiding innovators not only in building advanced technologies, but in ensuring they are trusted, scalable, and impactful in real-world settings.